Solexa Limited has completed its previously announced merger with Lynx Therapeutics, and will follow the deal with the release of a multi-faceted gene-analysis platform later this year, the new company announced this week.

The new entity, to be called Solexa, said that it had incorporated itself in the US as Solexa, Inc., and that Solexa Ltd. has become its wholly owned UK subsidiary. The company received approval for listing on the Nasdaq SmallCap Market and began trading March 7 under the ticker symbol SLXA.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Chinese state news agency Xinhua reports that a preliminary investigation has found He Jiankui performed his gene-editing work illegally.

John Mendelsohn, a former president of the University of Texas MD Anderson Cancer Center, has died, the New York Times reports.

Identical twins receive different estimates of ancestry from the same direct-to-consumer genetic testing firms, CBC reports.

In PNAS this week: chromosomal features of maize, adaptations in the vinous-throated parrotbill, and more.